CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer
Clinical Validation Of A Diagnostic Cancerend24 Screening As An Aid To The Clinician For The Diagnosis Of Cancer In Healthy Subjects Attending The ICPC
Tel-Aviv Sourasky Medical Center
2,000 participants
Sep 3, 2024
OBSERVATIONAL
Conditions
Summary
The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.
Eligibility
Inclusion Criteria3
- Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information
- Willing and able to sign an informed consent
- Age ≥40 years
Exclusion Criteria7
- Age < 40 years
- Pregnancy or breastfeeding
- Any type of fever
- Any cancer active at study entry or up to 5 years prior to study entry
- Polyposis syndromes
- Inflammatory bowel disease
- Unwilling or unable to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Venous blood sample will be taken from the patient as part of the routine blood tests taken as part of the work at the Medical Center
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06656728